Azithromycin in viral infections
Azithromycin (AZM) is a synthetic macrolide antibiotic effective against a broad range of bacterial and mycobacterial infections. Due to an additional range of anti‐viral and anti‐inflammatory properties, it has been given to patients with the coronaviruses SARS‐CoV or MERS‐CoV. It is now being inve...
主要な著者: | Oliver, ME, Hinks, TSC |
---|---|
フォーマット: | Journal article |
言語: | English |
出版事項: |
Wiley
2020
|
類似資料
-
Azithromycin for mild-to-moderate COVID-19 - Authors' reply
著者:: Hinks, TSC
出版事項: (2021) -
Effects of azithromycin in severe eosinophilic asthma with concomitant monoclonal antibody treatment
著者:: Lavoie, G, 等
出版事項: (2024) -
Study of MAIT cell activation in viral infections in vivo
著者:: Hinks, TSC, 等
出版事項: (2019) -
Boosting MAIT cells as immunotherapy: Context is everything
著者:: Hinks, TSC
出版事項: (2020) -
Azithromycin for mild-to-moderate COVID-19: author's reply
著者:: Hinks, TSC, 等
出版事項: (2021)